Spinout success
Imperial medical technology spinout raises $11 million
An imperial spinout company behind a digital therapy and rehabilitation platform has secured $11 million of investment funding.
Imperial medical technology spinout raises $11 million
An imperial spinout company behind a digital therapy and rehabilitation platform has secured $11 million of investment funding.
Kisspeptin hormone can enhance human bone activity
Kisspeptin, a naturally-occurring hormone, has been found to increase the activity of bone-forming cells in the body for the first time.
Imperial expert’s book uses scientific evidence to help people lose weight
An Imperial researcher specialising in obesity has published a new book aiming to help people reach a healthy body weight.
Trial identifies most effective breathing support for children in intensive care
A commonly used means of delivering extra oxygen to children in intensive care is not as effective as many clinicians assume, new research has found.
Imperial awarded £11.3 million for early stage clinical research
Imperial has been awarded £11.3 million by the National Institute of Health Research (NIHR) to support the delivery of clinical research.
Survivors of heart attack plus cardiac arrest at increased risk of early death
Patients who survive a heart attack together with sudden cardiac arrest are at increased risk of dying within six years following hospital discharge.
Ultrasound scan can diagnose prostate cancer
An ultrasound scan can be used to detect cases of prostate cancer, according to new research.
Audio
Podcast: Debating vaccines, LGBTQ+ history month, and humans of health research
In this edition: A scientist countering vaccine misinformation, members of Imperial’s LGBTQ+ network, and the people behind an impactful asthma trial.
Portrait exhibition celebrates staff and patients in healthcare research
A new series of portraits documenting researchers and patients involved in healthcare research has been unveiled in an online photography exhibition.
Researchers awarded £1m to trial quicker diagnostic tools for prostate cancer
Researchers have been awarded £1 million to trial new MRI scanning methods to diagnose prostate cancer.